News Release

View printer-friendly version
«Back
RadiSys Announces Third Quarter 2008 Results
  • Revenue of $100.3 million, up 20% year-over-year and a record for the Company
  • GAAP Net Loss per share of 1 cent, Non-GAAP EPS of 21 cents, up 75% year-over-year

HILLSBORO, Ore.--(BUSINESS WIRE)--RadiSys® Corporation (NASDAQ: RSYS), a leading global provider of advanced embedded solutions, today announced revenues of $100.3 million for the quarter ended September 30, 2008, up 20% versus the same quarter last year. The Company had a net loss of $0.2 million or $0.01 per share and Non-GAAP net income of $5.7 million or $0.21 per diluted share. Non-GAAP results exclude a loss of approximately $0.22 per share attributable to the impact of amortization of acquired intangible assets and stock-based compensation expense.

Commenting on the third quarter results, Scott Grout, RadiSys President and CEO stated, The results for the quarter reflect the significant progress weve made executing on our strategy to provide higher value next-generation embedded solutions. We have seen meaningful growth in demand for both our ATCA and Media Server product lines this year with a number of new customers. Our gross margin rate has improved from the mid 20s last year to over 30% in the third quarter on a non-GAAP basis. We made tremendous progress on our overall operating results in the third quarter and generated $7 million in cash flow from operating activities. We also significantly strengthened our balance sheet and ended the third quarter with $140 million in total cash and investments.

Third Quarter Financial Highlights

  • Revenue was $100.3 million, up 20% over the prior year. Revenue growth over the prior year was attributed to increases in next-generation communications, medical and other commercial market revenues. Growth in next-generation communications revenue was partially due to revenue recognized in the third quarter for shipments in prior quarters.
  • GAAP gross margin was 26.7%, up 3.8 points year-over-year. Non-GAAP gross margin was 30.8%, up 3.4 points year-over-year and up 1.4 points from the second quarter, due to a greater mix of next-generation higher margin products.
  • Total GAAP R&D and SG&A expenses were $24.7 million versus $23.7 million in the prior year and down $1.5 million compared with the prior quarter. Non-GAAP R&D and SG&A expenses were $22.5 million versus $21.0 million in the prior year and $23.9 million in the prior quarter.
  • GAAP operating income improved to $0.8 million or 0.8% of revenues versus a loss of $5.4 million in the same quarter last year. Non-GAAP operating income improved to $8.3 million or 8.3% of revenues versus $1.9 million or 2.3% of revenues in the same quarter last year.
  • Cash flow from operating activities was $6.9 million in the third quarter and was $23.2 million in the nine months ended September 30, 2008, compared with $6.0 million in the nine months ended September 30, 2007.
  • In October, the Company accepted an offer from UBS that will require the bank to repurchase, at par, all $62.7 million in student loan Auction Rate Securities (ARS's) held by the Company no later than June 30, 2010. The Company is also eligible for a no net interest loan for 75% of the market value of the ARSs until they are repurchased by UBS.

Third Quarter New Product Highlights

  • New Product Deployments
  • Q3 year to date 2008 next-generation communication revenues are tracking to the previous projection of over $90 million for the full year.
  • A new "Tier 1" customer entered into the field trial phase for a wireless networking product based on the RadiSys ATCA platform.
  • The RadiSys RMS420 image processing server was production released in the third quarter for two of the Company's "Tier 1" medical imaging customers and production shipments are expected to begin in the fourth quarter.
  • New Product Wins Q3 wins were in applications such as satellite broadband service, Gigabit Passive Optical Network (GPON), medical diagnostic, medical imaging, conferencing, telecom test and measurement, video network monitoring, session boarder controller, in-vehicle computer, security, packet inspection and industrial automation.
  • Promentum® ATCA Product Announcements RadiSys announced a new high-capacity 16-slot platform providing the maximum number of billable application slots in an ATCA carrier-grade system. This platform delivers the highest density of 10-Gigabit switching, packet processing and media processing capabilities available in a managed ATCA platform. RadiSys also announced a new low-profile 2-slot ATCA platform that provides a scalable solution for specialized appliances such as security and traffic management. RadiSys also launched a new validation lab for global partners and customers to remotely test, validate and/or demonstrate their unique solutions on RadiSys ATCA platforms. Finally, RadiSys was chosen as the Best-of-Show Award winner by the AdvancedTCA Summit for the Promentum® ATCA-9100 Media Resource Module.
  • Convedia® Media Server Product Announcements RadiSys announced a comprehensive set of features targeted at contact center applications using the RadiSys IP media server platform. The Convedia product family has real-time audio, video, and new embedded fax media processing capabilities that provide a common, feature-rich platform that fulfills next-generation contact center requirements.
  • Procelerant® COM Express Product Announcements RadiSys announced the availability of four new COM Express modules all powered by Intel Core 2 Duo Processor technology and the Mobile Intel GS45/GM45 Express chipsets. The new compact COMs are ideal for portable devices for medical and machine imaging that mandate processing performance, high-throughput communications and low power.

Fourth Quarter and Annual 2008 Outlook

The following statements are based on current expectations as of the date of this press release. These statements are forward-looking, and actual results may differ materially. Given the ongoing global economic turmoil, the Companys estimates are subject to a higher level of uncertainty than usual and assume no material reductions in demand in the Companys target markets. The Company assumes no obligation to update these statements.

  • Q4 revenue is expected to be between $81 and $87 million and down sequentially due in part to higher deferred ATCA revenues recognized in the third quarter as well as a projected sequential decrease in wireless revenues.
  • Q4 GAAP results are expected to be a net loss of $0.29 to $0.16 per share. Q4 non-GAAP results are expected to be net income of $0.06 to $0.12 per diluted share.
  • Q4 GAAP and non-GAAP gross margin percentages are expected to be similar to the third quarter at the midpoint of the guidance range.
  • Total Q4 R&D and SG&A expenses are expected to be down sequentially by approximately $750 thousand, at the midpoint of the guidance range, as a result of previously announced expense reductions.
  • 2008 next-generation communication revenues, comprised of ATCA and media server products, are projected to be at or above the Companys prior expectations of over $90 million.

In closing, Scott Grout stated, While we are seeing more uncertainty in projected demand due to macro-economic factors, bookings thus far are tracking to our fourth quarter outlook. I continue to be very pleased with our financial and strategic results this year, including the growing momentum with our new higher value products as well as our progress in increasing our gross margin rate.

Conference Call and Webcast Information

RadiSys will host a conference call on Tuesday, October 28, 2008, at 5:00 p.m. ET to discuss the third quarter results and review the financial and business outlook for the fourth quarter of 2008.

To participate in the live conference call, dial 888-333-0027 in the U.S. and Canada or 706-634-4990 for all other countries and reference conference ID#68725746. The live conference call will also be available via webcast on the RadiSys investor relations website at http://investor.radisys.com/.

A replay of the conference call will be available two hours after the call is complete until 11:59 p.m. ET on Tuesday, November 11, 2008. To access the replay, dial 800-642-1687 in the U.S. and Canada or 706-645-9291 for all other countries with conference ID#68725746. A replay of the webcast will be available for an extended period of time on the RadiSys investor relations website at http://investor.radisys.com/.

Forward-Looking Statements

This press release contains forward-looking statements, including statements about the Companys business strategy, outlook and guidance for the fourth quarter. Actual results could differ materially from the outlook, guidance and expectations in these forward-looking statements as a result of a number of risk factors, including, among others, (a) the Companys dependence on certain customers and high degree of customer concentration, (b) the anticipated amount and timing of revenues from design wins due to the Companys customers product development time, cancellations or delays, (c) the current economic uncertainty and turmoil within the global financial markets, (d) the Companys inability to realize the benefits sought from the acquisition of Convedia Corporation and Intel MCPD, which may adversely affect the price of the Companys stock, (e) the impact of failed auctions for auction rate securities held by the Company, and (f) the factors listed in RadiSys reports filed with the Securities and Exchange Commission (SEC), including those listed under Risk Factors in RadiSys Annual Report on Form 10-K for the year ended December 31, 2007, and in the RadiSys Quarterly Reports on Form 10-Q filed with the SEC each fiscal quarter, and other filings with the SEC, copies of which may be obtained by contacting the Company at 503-615-1100 or from the Companys investor relations web site at http://investor.radisys.com/ . Although forward-looking statements help provide additional information about RadiSys, investors should keep in mind that forward-looking statements are inherently less reliable than historical information. All information in this press release is as of October 28, 2008. The Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Companys expectations.

Non-GAAP Financial Measures

To supplement its condensed consolidated financial statements in accordance with generally accepted accounting principles (GAAP), the Companys earnings release contains non-GAAP financial measures that exclude certain expenses, gains and losses, such as the effects of (a) acquisition-related expenses including an in-process R&D charge, amortization of acquired intangible assets, amortization of deferred compensation, integration expenses and purchase accounting adjustments, (b) stock-based compensation expense recognized as a result of the Companys adoption of FAS 123R, (c) restructuring charges (reversals), (d) insurance gain, (e) a gain related to supplier settlement, and (f) a gain related to the sale of a building /land. The Company believes that the use of non-GAAP financial measures provides useful information to investors to gain an overall understanding of its current financial performance and its prospects for the future. Specifically, the Company believes the non-GAAP results provide useful information to both management and investors by excluding certain expenses, gains and losses that the Company believes are not indicative of its core operating results. In addition, non-GAAP financial measures are used by management for budgeting and forecasting as well as subsequently measuring the Companys performance, and the Company believes that it is providing investors with financial measures that most closely align to its internal measurement processes. These non-GAAP measures are considered to be reflective of the Companys core operating results as they more closely reflect the essential revenue-generating activities of the Company and direct operating expenses (resulting in cash expenditures) needed to perform these revenue-generating activities. The Company also believes, based on feedback provided to the Company during its earnings calls Q&A sessions and discussions with the investment community, that the non-GAAP financial measures it provides are necessary to allow the investment community to construct their valuation models to better align its results and projections with its competitors and market sector, as there is significant variability and unpredictability across companies with respect to certain expenses, gains and losses. Accordingly, management excludes the amortization of acquired intangible assets primarily related to the Convedia and Intel MCPD acquisitions, stock-based compensation expense and significant and non-recurring charges and gains.

The non-GAAP financial information is presented using consistent methodology from quarter-to-quarter and year-to-year. These measures should be considered in addition to results prepared in accordance with GAAP. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. The Company believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with the Companys results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate the Companys results of operations in conjunction with the corresponding GAAP financial measures.

A reconciliation of non-GAAP information to GAAP information is included in the tables below. The non-GAAP financial measures disclosed by the Company should not be considered a substitute for or superior to financial measures calculated in accordance with GAAP, and reconciliations between GAAP and non-GAAP financial measures included in this earnings release should be carefully evaluated. The non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies.

About RadiSys

RadiSys (NASDAQ: RSYS) is a leading provider of advanced embedded solutions for the communications networking and commercial systems markets. Through intimate customer collaboration and combining innovative technologies and industry leading architecture, RadiSys helps original equipment manufacturers, systems integrators and solution providers bring better products to market faster and more economically. RadiSys products include embedded boards, application enabling platforms and turn-key systems, which are used in todays complex computing, processing and network intensive applications. For more information, visit http://www.radisys.com, write to info@radisys.com, or call 800-950-0044 or 503-615-1100. Editors seeking more information may contact Lyn Pangares at RadiSys Corporation at 503-615-1220 or lyn.pangares@radisys.com.

RadiSys®, Convedia®, Promentum® and Procelerant® are registered trademarks of RadiSys Corporation. All other trademarks are property of their respective owners.

CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts, unaudited)
       
Three Months Ended Nine Months Ended
September 30, September 30,
2008 2007 2008 2007
Revenues $100,258 $83,630 $283,916 $226,013
Cost of sales:
Cost of sales 69,652 60,907 201,191 165,348
Amortization of purchased technology 3,868   3,532   11,906   9,999  
Total cost of sales 73,520   64,439   213,097   175,347  
Gross margin 26,738 19,191 70,819 50,666
Research and development 11,896 11,775 37,593 34,084
Selling, general, and administrative 12,763 11,889 38,715 35,146
Intangible assets amortization 1,302 1,078 3,907 3,124
Restructuring and other charges (reversals) (23 ) (141 ) 575   1,391  
Income (loss) from operations 800 (5,410 ) (9,971 ) (23,079 )
Interest expense (672 ) (416 ) (1,933 ) (1,279 )
Interest income 605 1,690 2,555 4,946
Other income (expense), net 27   (30 ) 36   (151 )
Income (loss) before income taxes 760 (4,166 ) (9,313 ) (19,563 )
Income tax expense (benefit) 1,006   (1,720 ) 45   (4,401 )
Net loss ($246 ) ($2,446 ) ($9,358 ) ($15,162 )
Net loss per share:
Basic ($0.01 ) ($0.11 ) ($0.42 ) ($0.70 )

Diluted (I), (II)

($0.01 ) ($0.11 ) ($0.42 ) ($0.70 )
Weighted average shares outstanding:
Basic 22,653   21,937   22,442   21,808  
Diluted (I), (II) 22,653   21,937   22,442   21,808  
 
 

(I) For the three and nine months ended September 30, 2007, options amounting to 3.3 million shares were excluded from the calculation as the Company was in a loss position. For the three and nine months ended September 30, 2008, options amounting to 3.5 million shares were excluded from the calculation as the Company was in a loss position.

 
 

(II) For the three and nine months ended September 30, 2007 and 2008, as-if converted shares associated with the 2023 convertible senior notes were excluded from the calculation as the affect would have been anti-dilutive. For the three and nine months ended September 30, 2007, the total number of as-if converted shares associated with the 2023 convertible senior notes was 4.2 million. For the three and nine months ended September 30, 2008, the total combined number of as-if converted shares associated with the 2023 convertible senior notes was 1.6 million and 2.3 million shares, respectively. For the three and nine months ended September 30, 2008, as-if converted shares associated with the 2013 convertible senior notes were excluded from the calculation as the affect would have been anti-dilutive. For the three and nine months ended September 30, 2008, the total combined number of as-if converted shares associated with the 2013 convertible senior notes was 4.2 million and 3.5 million shares, respectively.

CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)
   
September 30, December 31,
2008 2007 (I)
ASSETS
Current assets:
Cash and cash equivalents $83,676 $50,522
Short-term investments 72,750
Accounts receivable, net 49,129 70,548
Other receivables 1,995 2,678
Inventories, net 31,351 23,101
Other current assets 3,674 5,299
Deferred tax assets, net 6,603   6,489  
Total current assets 176,428   231,387  
 
Property and equipment, net 11,757 11,233
Goodwill 67,644 67,644
Intangible assets, net 22,950 38,779
Long-term investments, net 56,522
Long-term deferred tax assets, net 42,110 40,078
Other assets 5,449   3,987  
Total assets $382,860   $393,108  
 
LIABILITIES AND SHAREHOLDERS EQUITY
Current liabilities:
Accounts payable $37,857 $49,675
Accrued wages and bonuses 8,693 8,101
Deferred revenue 3,073 5,308
2023 convertible senior notes, net 36,623 97,548
Other accrued liabilities 10,890   8,915  

Total current liabilities

97,136   169,547  
Long-term liabilities:
2013 convertible senior notes, net 55,000
Revolving line of credit 20,000
Other long-term liabilities 3,260   3,585  
Total long-term liabilities 78,260   3,585  
Total liabilities 175,396   173,132  
Shareholders equity :
Preferred stock $.01 par value, 5,664 shares authorized; none issued or outstanding
Common stock no par value, 100,000 shares authorized; 22,848 and 22,312 shares issued and outstanding at September 30, 2008 and December 31, 2007 227,918 226,873
Accumulated deficit (20,643 ) (11,285 )
Accumulated other comprehensive income:
Cumulative translation adjustments 4,395 4,388
Unrealized loss on hedge instruments (246 )
Unrealized loss on available-for-sale investments (3,960 )  
Total accumulated other comprehensive income 189   4,388  
Total shareholders equity 207,464   219,976  
Total liabilities and shareholders equity $382,860   $393,108  
 
 
(I) Certain reclassifications have been made to amounts in prior years to conform to current year presentation.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
       
Three Months Ended Nine Months Ended
September 30, September 30,
2008 2007 2008 2007
Cash flows from operating activities:
Net loss ($246 ) ($2,446 ) ($9,358 ) ($15,162 )
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization 6,757 6,537 20,534 19,245
Inventory valuation allowance 1,395 1,472 2,872 5,179
Deferred income taxes 973 (1,366 ) 70 (4,976 )
Gain on early extinguishment of debt - - (37 ) -
Stock-based compensation expense 2,378 2,544 7,426 7,425
Provisions for allowance for doubtful accounts 13 3 170 7
Other 147 225 531 111
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable 6,650 (2,264 ) 21,284 (17,690 )
Other receivables 976 956 683 1,478
Inventories 787 906 (11,122 ) 3,624
Other current assets 618 1,267 2,077 1,571
Accounts payable (8,621 ) 3,456 (11,827 ) 3,209
Accrued wages and bonuses (1,571 ) (343 ) 608 (127 )
Deferred revenue (2,729 ) 1,197 (2,294 ) 1,614
Other accrued liabilities (628 ) (1,572 ) 1,607   475  
Net cash provided by operating activities 6,899   10,572   23,224   5,983  
 
Cash flows from investing activities:
Proceeds from the sale of auction rate securities - 26,400 10,025 50,100
Purchase of auction rate securities - (5,000 ) - (17,850 )
Capital expenditures (1,329 ) (1,084 ) (4,951 ) (3,759 )
Acquisition of MCPD - (32,032 ) - (32,032 )
Proceeds from the sale of property and equipment - 824 - 3,032
Other 51   -   (280 ) (106 )
Net cash (used in) provided by investing activities (1,278 ) (10,892 ) 4,794   (615 )
 
Cash flows from financing activities:
Financing costs - - (2,539 ) -
Proceeds from issuance of 2013 convertible senior notes - - 55,000 -
Purchase of capped call - - (10,154 ) -
Payments on capital lease obligation (24 ) - (101 ) -
Repurchase of 2023 convertible senior notes (1 ) (2,416 ) (60,916 ) (2,416 )
Net settlement of restricted shares (37 ) (48 ) (390 ) (301 )

Borrowings on revolving line of credit

20,000 - 20,000 -
Proceeds from issuance of common stock 1,626   1,129   4,163   3,614  
Net cash provided by (used in) financing activities 21,564   (1,335 ) 5,063   897  
 
Effect of exchange rate changes on cash (154 ) 229   73   246  
Net increase (decrease) in cash and cash equivalents 27,031 (1,426 ) 33,154 6,511
Cash and cash equivalents, beginning of period 56,645   31,671   50,522   23,734  
Cash and cash equivalents, end of period $83,676   $30,245   $83,676   $30,245  
 
Supplemental non-cash disclosures:
Capital lease obligation $204 $204
REVENUE BY GEOGRAPHY
(In thousands, unaudited)
       
Three Months Ended Nine Months Ended
September 30, September 30,
2008 2007 2008 2007
North America $33,140 $23,374 $87,071 $77,306
Europe 37,274 36,385 109,526 91,679
Asia Pacific 29,844 23,871 87,319 57,028
Total $100,258 $83,630 $283,916 $226,013
 
North America 33.0% 27.9% 30.7% 34.2%
Europe 37.2% 43.6% 38.5% 40.6%
Asia Pacific 29.8% 28.5% 30.8% 25.2%
Total 100.0% 100.0% 100.0% 100.0%
REVENUE BY MARKET
(In thousands, unaudited)
       
Three Months Ended Nine Months Ended
September 30, September 30,
2008 2007 2008 2007
 
Wireless $38,011 $42,953 $117,107 $94,689
IP Networking & Messaging 13,065 15,879 38,843 55,382
Other Communications Networking 27,245 5,302 67,594 18,005
Total Communications Networking 78,321 64,134 223,544 168,076
Medical 8,418 7,574 21,908 25,389
Other Commercial 13,519 11,922 38,464 32,548
Total Commercial 21,937 19,496 60,372 57,937
Total Company $100,258 $83,630 $283,916 $226,013
 
Wireless 37.9% 51.4% 41.2% 41.9%
IP Networking & Messaging 13.0% 19.0% 13.7% 24.5%
Other Communications Networking 27.2% 6.3% 23.8% 8.0%
Total Communications Networking 78.1% 76.7% 78.7% 74.4%
Medical 8.4% 9.0% 7.7% 11.2%
Other Commercial 13.5% 14.3% 13.6% 14.4%
Total Commercial 21.9% 23.3% 21.3% 25.6%
Total Company 100.0% 100.0% 100.0% 100.0%
RECONCILIATION OF GAAP to NON-GAAP FINANCIAL MEASURES
(In thousands, except per share amounts, unaudited)
       
Three Months Ended Nine Months Ended
September 30, September 30,
2008 2007 2008 2007
GROSS MARGIN:
GAAP gross margin $26,738     $19,191   $70,819     $50,666  
(a) Amortization of acquired intangible assets (I) 3,868 3,532 11,906 9,999
(b) Amortization of deferred compensation - 17 - 67
(d) Purchase accounting adjustments - - - 250
(e) Stock-based compensation 254     195   768     727  
Total Non-GAAP adjustments 4,122     3,744   12,674     11,043  
Non-GAAP gross margin $30,860     $22,935   $83,493     $61,709  
RESEARCH AND DEVELOPMENT:
GAAP research and development $11,896     $11,775   $37,593     $34,084  
(b) Amortization of deferred compensation - (106 ) - (426 )
(e) Stock-based compensation (746 )   (716 ) (2,343 )   (2,030 )
Total Non-GAAP adjustments (746 )   (822 ) (2,343 )   (2,456 )
Non-GAAP research and development $11,150     $10,953   $35,250     $31,628  
SELLING, GENERAL AND ADMINISTRATIVE:
GAAP selling, general and administrative $12,763     $11,889   $38,715     $35,146  
(b) Amortization of deferred compensation - (193 ) - (757 )
(c) Integration expenses - - - (377 )
(d) Purchase accounting adjustments - (90 ) - (269 )
(e) Stock-based compensation (1,378 ) (1,633 ) (4,315 ) (4,668 )
(f) Gain on sale of building -     77   -     212  
Total Non-GAAP adjustments (1,378 )   (1,839 ) (4,315 )   (5,859 )
Non-GAAP selling, general and administrative $11,385     $10,050   $34,400     $29,287  
INCOME (LOSS) FROM OPERATIONS:
GAAP income (loss) from operations $800     ($5,410 ) ($9,971 )   ($23,079 )
(a) Amortization of acquired intangible assets (I) 5,170 4,610 15,813 13,123
(b) Amortization of deferred compensation - 316 - 1,250
(c) Integration expenses - - - 377
(d) Purchase accounting adjustments - 90 - 519
(e) Stock-based compensation 2,378 2,544 7,426 7,425
(f) Restructuring and other charges (23 ) (141 ) 575 1,391
(g) Gain on sale of building -     (77 ) -     (212 )
Total Non-GAAP adjustments 7,525     7,342   23,814     23,873  
Non-GAAP income from operations $8,325     $1,932   $13,843     $794  
NET INCOME (LOSS):
GAAP net loss ($246 )   ($2,446 ) ($9,358 )   ($15,162 )
(a) Amortization of acquired intangible assets (I) 5,170 4,610 15,813 13,123
(b) Amortization of deferred compensation - 316 - 1,250
(c) Integration expenses - - - 377
(d) Purchase accounting adjustments - 90 - 519
(e) Stock-based compensation 2,378 2,544 7,426 7,425
(f) Restructuring and other charges (23 ) (141 ) 575 1,391

(g) Gain on sale of building/land

- (77 ) - (212 )
(h) Income tax effect of reconciling items (1,562 )   (1,997 ) (4,889 )   (5,005 )
Total Non-GAAP adjustments 5,963     5,345   18,925     18,868  
Non-GAAP net income $5,717     $2,899   $9,567     $3,706  
GAAP weighted average shares (diluted) 22,653 21,937 22,442 21,808
Non-GAAP adjustment 6,420     4,923   6,411     5,009  
Non-GAAP weighted average shares (diluted) (II) 29,073     26,860   28,853     26,817  
GAAP net loss per share (diluted) ($0.01 ) ($0.11 ) ($0.42 ) ($0.70 )
Non-GAAP adjustments detailed above $0.22     $0.23   $0.79     $0.86  
Non-GAAP net income per share (diluted) (II) $0.21     $0.12   $0.37     $0.17  

 

 
(I) Amortization of acquired intangible assets excluded from non-GAAP results includes Convedia, Intel MCPD, and Microware amortization. Microware amortization expense was previously included in non-GAAP results. Prior periods have been adjusted to reflect the current period presentation.
 

(II) For the three and nine months ended September 30, 2007, dilutive equity awards amounting to 681,000 and 692,000 shares, respectively, were included in the calculation. For the three and nine months ended September 30, 2008, dilutive equity awards amounting to 608,000 and 624,000 shares, respectively, were included in the calculation. For the three and nine months ended September 30, 2007, the number of diluted weighted average shares outstanding calculation includes 4.2 million shares underlying our 2023 convertible senior notes; as a result, the diluted earnings per share calculation excludes the interest expense, net of tax benefit, which amounted to $251,000 and $752,000 for the three and nine months ended September 30, 2008. For the three and nine months ended September 30, 2008, the number of diluted weighted average shares outstanding calculation includes 5.8 million underlying our 2023 and 2013 convertible senior notes; as a result, the diluted earnings per share calculation excludes the interest expense, net of tax benefit, which amounted to $321,000 and $810,000 for the three and nine months ended September 30, 2008.

RECONCILIATION OF GAAP TO NON-GAAP LINE ITEMS AS A PERCENT OF REVENUE AND EFFECTIVE TAX RATE FOR THE QUARTER ENDED SEPTEMBER 30, 2008

(Unaudited)
           
Gross Income Income Effective
Margin   R&D   SG&A   from Ops   before tax   Tax Rate
GAAP 26.7%   11.9%   12.7%   0.8%   0.8%   132.4%
(a) Amortization of acquired intangible assets 3.8 5.1 5.1 (69.4)
(e) Stock-based compensation 0.3   (0.8)   (1.3)   2.4   2.4   (31.6)
Non-GAAP 30.8%   11.1%   11.4%   8.3%   8.3%   31.4%

 

 

 

 

 

The Company excludes the following expenses, reversals, gains and losses from its non-GAAP financial measures, when applicable:

(a) Amortization of acquired intangible assets: Amortization of acquisition-related intangible assets primarily relate to core and existing technologies, patents, trade name and customer relationships that were acquired with the acquisition of Convedia and MCPD. The Company excludes the amortization of acquisition-related intangible assets because it does not reflect the Company's ongoing business and it does not have a direct correlation to the operation of the Company's business. In addition, in accordance with GAAP, the Company generally recognizes expenses for internally-developed intangible assets as they are incurred, notwithstanding the potential future benefit such assets may provide. Unlike internally-developed intangible assets, however, and also in accordance with GAAP, the Company generally capitalizes the cost of acquired intangible assets and recognizes that cost as an expense over the useful lives of the assets acquired (other than goodwill, which is not amortized, and acquired in-process technology, which is expensed immediately, as required under GAAP). As a result of their GAAP treatment, there is an inherent lack of comparability between the financial performance of internally-developed intangible assets and acquired intangible assets. Accordingly, the Company believes it is useful to provide, as a supplement to its GAAP operating results, non-GAAP financial measures that exclude the amortization of acquired intangibles in order to enhance the period-over-period comparison of its operating results, as there is significant variability and unpredictability across companies with respect to this expense.

 
 
(b) Amortization of deferred compensation: Deferred compensation expense consists of amortized expenses related to 25% of the purchase price per share less the exercise price of Convedia stock options to be paid to Convedia employees still employed by RadiSys after one year of service. The Company excludes the amortization of deferred compensation expense because it does not reflect the Company's ongoing business and it does not have a direct correlation to the operation of the Company's business.
 
 
(c) Integration expenses: Integration expenses consist of expenses related to the integration effort between the Company and Convedia. The Company excludes integration expenses because it does not reflect the Company's ongoing business and it does not have a direct correlation to the operation of the Company's business.
 
 
(d) Purchase accounting adjustments: Purchase accounting adjustments consist of adjustments for fair value accounting treatment of Convedia assets. These adjustments relate to the write-down of deferred revenue to the cost to complete the revenue earnings process. The Company excludes the purchase accounting adjustments because it does not reflect the Company's ongoing business and it does not have a direct correlation to the operation of the Company's business.
 
 
(e) Stock-based compensation: Stock-based compensation consists of expenses recorded under SFAS 123(R), "Share-Based Payment," in connection with stock awards such as stock options, restricted stock awards and restricted stock units granted under the Company's equity incentive plans and shares issued pursuant to the Company's employee stock purchase plan. The Company excludes stock-based compensation from non-GAAP financial measures because it is a non-cash measurement that does not reflect the Company's ongoing business and because the Company believes that investors want to understand the impact on the Company of the adoption of SFAS 123(R); the Company believes that the provision of non-GAAP information that excludes stock-based compensation improves the ability of investors to compare its period-over-period operating results, as there is significant variability and unpredictability across companies with respect to this expense.
 
 
(f) Restructuring and other charges (reversals): Restructuring and other charges primarily relate to activities engaged in by the Companys management to simplify its infrastructure. Restructuring and other charges are excluded from non-GAAP financial measures because they are not considered core operating activities and the occurrence of such costs are infrequent. Although the Company has engaged in various restructuring activities over the past several years, each has been a discrete, extraordinary event based on a unique set of business objectives. The Company does not engage in restructuring activities on a regular basis or in the ordinary course of business. As such, the Company believes it is appropriate to exclude restructuring charges from its non-GAAP financial measures, as it enhances the ability of investors to compare the Companys period-over-period operating results.
 
 
(g) Other special items: This amount arises from the sale of a building in the second quarter of 2007. The Company excludes special items, such as this, because the transaction does not reflect the Companys ongoing business and does not have a direct correlation to the operation of the Companys business.
 
 

(h) Income taxes: Income tax provision/(benefit) associated with non-GAAP adjustments.

RECONCILIATION OF GAAP TO NON-GAAP GUIDANCE
NET INCOME (LOSS) AND NET INCOME (LOSS) PER SHARE
(Dollars in millions and shares in thousands, except per share amounts, unaudited)
   
Three Months Ended
December 31, 2008
Low End High End
GAAP net loss (assumes tax rate of -20%) ($6.6 ) ($3.7 )
Amortization of acquired intangible assets 4.8 4.8
Stock-based compensation 2.3 2.3
Loss on extinguishment of debt (2023 Convert) 0.9 0.9
Income tax effect of reconciling items 0.1   (1.3 )
Total adjustments $8.1   $6.7  
Non-GAAP net income (assumes tax rate of 40%) $1.5   $3.0  
 
GAAP weighted average shares (diluted) (I) 22,863 22,863
Non-GAAP adjustment 483   5,500  
Non-GAAP weighted average shares (diluted) (II) 23,346   28,363  
 
GAAP net income (loss) per share (diluted) (I) ($0.29 ) ($0.16 )
Non-GAAP adjustments detailed above 0.35   0.28  
Non-GAAP net income per share (diluted) (II) $0.06   $0.12  
 
 

(I) The effects of the 2023 and 2013 convertible senior notes were excluded in the computation of diluted earnings per share as the effect would be anti-dilutive.

 

 

(II) The low end diluted weighted average shares outstanding excludes the effects of the 2023 and 2013 convertible senior notes in the computation of diluted earnings per share as the effect would be anti-dilutive. The high end diluted weighted average shares outstanding includes the effects of the shares underlying the 2023 and 2013 convertible senior notes, and as a result the diluted earnings per share calculation excludes the interest expense for the converts, net of tax. Total net interest expense added back to net income amounts to $383 thousand.

RECONCILIATION OF GAAP TO NON-GAAP GUIDANCE
RESEARCH AND DEVELOPMENT EXPENSE AND
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE
(In millions, unaudited)
   
Estimates at the midpoint of
the Revenue and Per Share
Guidance for the Quarter
Ended September 30, 2008
R&D SG&A
GAAP $11.3   $12.6  
Stock-based compensation (0.7 ) (1.4 )
Non-GAAP $10.6   $11.2  

Contacts:

RadiSys Corporation
Chief Financial Officer
Brian Bronson, 1-503-615-1281
brian.bronson@radisys.com
or
Finance and Investor Relations Manager
Holly Stephens, 1-503-615-1321
holly.stephens@radisys.com